{"schema_version":"secwatch.filing_event.v1","accession":"0001100682-21-000025","form_type":"8-K","ticker":"CRL","cik":"0001100682","company_name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","filed_at":"2021-12-15T23:59:59+00:00","discovered_at":"2026-05-14T18:04:11.491839+00:00","generated_at":"2026-06-28T00:46:24.484088+00:00","sec_items":["5.03","9.01"],"event_type":"other","sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"confidence":"high","headline":"Charles River Laboratories adopts proxy access bylaw amendment","bullets":["Stockholders owning at least 3% of outstanding stock for 3+ years can nominate directors.","Groups of up to 20 stockholders may aggregate ownership to meet the threshold.","Nominees can constitute up to the greater of 2 directors or 20% of the board.","Amendments effective December 13, 2021; includes conforming and routine updates."],"urls":{"canonical":"https://secwatch.observer/filing/0001100682-21-000025","json":"https://secwatch.observer/filing/0001100682-21-000025.json","markdown":"https://secwatch.observer/filing/0001100682-21-000025.md","text":"https://secwatch.observer/filing/0001100682-21-000025.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1100682/000110068221000025/0001100682-21-000025-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1100682/000110068221000025/crl-20211213.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-28T00:46:24.484088+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}